title: Some perspectives on dietary inhibition of carcinogenesis: studies with curcumin and tea.
abstract: Topical application of curcumin inhibits chemically induced carcinogenesis on mouse skin, and oral administration of curcumin inhibits chemically induced oral, forestomach, duodenal, and colon carcinogenesis. Curcumin and other inhibitors of cyclooxygenase and lipoxygenase are thought to inhibit carcinogenesis by preventing the formation of arachidonic acid metabolites. In contrast to our expectation of a tumorigenic effect of arachidonic acid, we found that treatment of 7,12-dimethylbenz[a]anthracene-initiated mouse skin with very high doses of arachidonic acid twice daily, 5 days a week for 26 weeks, failed to result in tumors. We considered the possibility that some of the cancer chemopreventive effects of curcumin may be related to an effect of this compound on cellular differentiation, and we investigated the effect of curcumin on differentiation in the human promyelocytic HL-60 leukemia cell model system. Although curcumin alone had little or no effect on cellular differentiation, when it was combined with all-trans retinoic acid or 1alpha,25-dihydroxyvitamin D3 a synergistic effect was observed. It is possible that many dietary chemicals in fruits, vegetables, and other edible plants can prevent cancer by synergizing with endogenously produced stimulators of differentiation such as all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and butyrate. More research is needed to test this hypothesis. Administration of green or black tea inhibits carcinogenesis in several animal models, and tumor growth is also inhibited. Several examples were presented of chemopreventive agents that inhibit carcinogenesis in one animal model but enhance carcinogenesis in a different animal model. Greater efforts should be made to understand mechanisms of cancer chemoprevention and to determine whether a potential chemopreventive agent is useful in many experimental settings or whether it is useful in only a limited number of experimental settings.
authors.affiliation: Department of Chemical Biology, College of Pharmacy, Rutgers, The State University of New Jersey, Piscataway 08855-0789, USA.
authors.forename: A H
authors.initials: AH
authors.lastname: Conney
authors.forename: Y R
authors.initials: YR
authors.lastname: Lou
authors.forename: J G
authors.initials: JG
authors.lastname: Xie
authors.forename: T
authors.initials: T
authors.lastname: Osawa
authors.forename: H L
authors.initials: HL
authors.lastname: Newmark
authors.forename: Y
authors.initials: Y
authors.lastname: Liu
authors.forename: R L
authors.initials: RL
authors.lastname: Chang
authors.forename: M T
authors.initials: MT
authors.lastname: Huang
mesh_terms: D000818:Animals; D016588:Anticarcinogenic Agents; D016718:Arachidonic Acid / Q000378:metabolism / Q000494:pharmacology; D002117:Calcitriol / Q000627:therapeutic use; D002273:Carcinogens / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects; D018890:Chemoprevention; D003474:Curcumin / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology*; D004032:Diet; D006801:Humans; D051379:Mice; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000517:prevention & control* / Q000628:therapy; D013662:Tea / Q000737:chemistry; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014212:Tretinoin / Q000494:pharmacology
chemical_list: D016588:Anticarcinogenic Agents; D002273:Carcinogens; D013662:Tea; D016718:Arachidonic Acid; D014212:Tretinoin; D002117:Calcitriol; D003474:Curcumin; D013755:Tetradecanoylphorbol Acetate